This concordance among tumor differentiation grade, disease stage, and serum CEA elevation reinforces the nomogram’s capability to integrate multiple independent prognostic factors into an actionable risk stratification framework, with distant metastasis (stage IV) serving as the primary determinant of high-risk classification. The gene discussed is CEACAM5; the disease is neoplasm.